Last reviewed · How we verify

NCT05788887: LadotyriCT

Investigation of the Postprandial Response of Two Different PDO Cheeses on Metabolic Biomarkers

Completed NA Last updated 14 April 2023
What this trial tests

NA trial testing Authentic Ladotyri Mytilinis PDO cheese in Healthy in 10 participants. Completed in 17 January 2022.

Timeline
10 January 2022
Primary endpoint
17 January 2022
17 January 2022

Quick facts

Lead sponsorUniversity of the Aegean
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeother
Enrollment10
Start date10 January 2022
Primary completion17 January 2022
Estimated completion17 January 2022
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

University of the Aegean

Who can join

Adults 18 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Postprandial Inflammatory and Metabolic Responses Induced by Authentic Mytilinis Cheese: A Preliminary, Crossover, Nutritional Intervention in Healthy Adults.
    Papagianni O, Voutsa A, Katira O, Potsaki P, et al · · 2023 · cited 1× · PMID 37109453 · DOI 10.3390/life13040923

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University of the Aegean trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05788887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing